CytomX Therapeutics Inc (CTMX) is higher by Monday morning, with the stock rising 3.50% in pre-market trading to 1.48. CTMX's short-term technical score of 39 indicates that the stock has traded less bullishly over the last month than 61% of stocks on the market. In the Biotechnology industry, which ranks 75 out of 146 industries, CytomX Therapeutics Inc ranks higher than 30% of stocks. CytomX Therapeutics Inc has fallen 22.28% over the past month, closing at $1.94 on July 4. During this period of time, the stock fell as low as $1.23 and as high as $2.01. CTMX has an average analyst recommendation of Buy. The company has an average price target of $3.95.
CTMX has an Overall Score of 46. Find out what this means to you and get the rest of the rankings on CTMX!